Business news – Page 21
-
FeatureThe growing problem of pesticide resistance
Weeds and other plant pests can no longer be controlled by chemicals as easily as they could. Bárbara Pinho talks to the scientists finding solutions
-
ArticleThe role of semiconductors in tomorrow’s technologies
Industry 4.0 demands more from semiconductors then ever before
-
ArticleUnlocking the future of medicines manufacturing with digital innovations
The Medicines Manufacturing Innovation Centre promises to revolutionise how we formulate, trial and produce medicines
-
BusinessAntibody–drug conjugates drive growth in oncology
Antibody–drug conjugates are coming of age and pharma is investing, reports Katrina Megget
-
OpinionHow the pandemic might change drug research
Derek Lowe muses on some positive lessons learned
-
BusinessWhy manufacturing Covid vaccines at scale is hard
Exploring the pinch points vaccine makers face as they ramp up production
-
OpinionRewards based on priority drive unnecessary competition
The story of Crispr illustrates how a focus on patents and publications can cause good people to act in unsavoury ways
-
CareersThe life of a chief scientific officer
A dream job for scientists who love to work with people
-
OpinionWhy are impurity regulations different for food and drugs?
The pharmaceutical and food industries should work together more closely on genotoxic impurities
-
FeatureFlow chemistry surges forward
The long-discussed technique could help make pharma manufacturing more distributed, finds Andy Extance, and create opportunities for chemists with the right skills
-
BusinessUniversity team’s silica coats stop vaccines spoiling at room temperature
Asel Sartbaeva hopes her pioneering ensilication technology will be adopted to store and transport pediatric vaccines to low-income countries
-
BusinessChromosol’s silicon photonics system tackles data transfer bottleneck
Technology for integrating lasers directly into photonic circuits could accelerate replacement of large and expensive optical systems
-
BusinessPolar storm paralyses US Gulf Coast petrochemical sector
Days after ‘icepocalypse’ hit Texas, 75% of US ethylene capacity was still offline, as was 70% of its polypropylene and 40% of propylene production
-
BusinessCoronavirus variants stymie success of monoclonal antibodies
Lab-made antibodies can treat and protect people from Covid-19 but are more likely to succeed when administered as a cocktail
-
BusinessBASF tightens austerity belt and closes plant in north of England
Political fallout over £1 billion Covid loan that preceded hexamethylene diamine plant closure
-
OpinionA rough guide to pharma partnership deals
Coronavirus vaccines are driving unusual collaborations with a range of benefits
-
WebinarGaining an edge through smarter experimentation
Learn how to double your R&D capacity and get more products to market in less time – and at a lower cost
-
BusinessBiggest venture yet of any pharma company into cannabis
Jazz Pharmaceuticals buys cannabinoid therapeutic firm for $7.2 billion, inheriting first plant-derived cannabinoid medicine ever approved by FDA
-
BusinessCovid vaccination efforts bolstered by trial results from J&J and Novavax
A miserable January ended with positive news on the vaccine front but new variants added complications
-
OpinionObserving the state’s transition
Sweeping changes on both sides of the Atlantic have yet to deliver on their promises